Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Teva Pharmaceutical Industries's share price for the quarter that ended in Dec. 2023 was $10.44. Teva Pharmaceutical Industries's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,121 Mil. Therefore, Teva Pharmaceutical Industries's market cap for the quarter that ended in Dec. 2023 was $11,704 Mil.
Teva Pharmaceutical Industries's quarterly market cap
increased
from Jun. 2023 ($8,438 Mil) to Sep. 2023 ($11,434 Mil) and
increased
from Sep. 2023 ($11,434 Mil) to Dec. 2023 ($11,704 Mil).
Teva Pharmaceutical Industries's annual market cap
increased
from Dec. 2021 ($8,838 Mil) to Dec. 2022 ($10,131 Mil) and
increased
from Dec. 2022 ($10,131 Mil) to Dec. 2023 ($11,704 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Teva Pharmaceutical Industries's Enterprise Value for Today is $31,233 Mil.
Teva Pharmaceutical Industries Market Cap Historical Data
The historical data trend for Teva Pharmaceutical Industries's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Teva Pharmaceutical Industries Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Market Cap
10,703.46
10,581.32
8,837.67
10,131.41
11,704.18
Teva Pharmaceutical Industries Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Market Cap
10,131.41
9,915.63
8,438.49
11,433.89
11,704.18
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teva Pharmaceutical Industries Market Cap Distribution
For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Market Cap distribution charts can be found below:
* The bar in red indicates where Teva Pharmaceutical Industries's Market Cap falls into.
Teva Pharmaceutical Industries Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Teva Pharmaceutical Industries's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teva Pharmaceutical Industries (NYSE:TEVA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Teva Pharmaceutical Industries Market Cap Related Terms
Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Business Description
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TEVA has been successfully added to your 